Shilpi Arora,Srividya Balasubramanian,William D. Bradley,Patrick Trojer
申请号：
US15747331
公开号：
US20180214519A1
申请日:
2015.07.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are pharmaceutical compositions comprising an EZH2 inhibitor and a type I interferon, processes for preparing such pharmaceutical compositions, and uses thereof in modulating the activity of histone methyl modifying enzymes.
